Literature DB >> 10644991

The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.

J M Summy1, A C Guappone, M Sudol, D C Flynn.   

Abstract

The c-src and c-yes proto-oncogenes encode 60 000 and 62 000 Dalton non-receptor tyrosine kinases of the Src family, pp60c-src and pp62c-yes, respectively. These kinases are over 80% homologous outside of their unique amino termini, yet several studies suggest that differences exist in the regulation, activation, and function of cSrc and cYes. The determinants of specificity in signaling between these proteins, however, remain unclear. In order to investigate the roles of the Src Homology (SH) 3 and 2 domains in mediating signaling specificity between cSrc and cYes, chimeras were created in which the SH3 and/or SH2 domains of cSrc or the fully activated variant Src527F were replaced by the corresponding domains of cYes. These constructs were used to assess the effects of the Yes SH3 and SH2 domains on the ability of Src to form stable complexes with and induce tyrosine phosphorylation of Src SH3 and SH2 domain binding partners in vivo. Both the Yes SH3 and SH2 domains were found to alter the capacity of Src to form stable associations with heterologous proteins. The Yes SH3 domain was unable to affinity absorb the Src SH3/SH2 binding partner AFAP-110 from COS-1 cell lysates, and chimeric constructs of Src527F containing the cYes SH3 domain were unable to efficiently co-immunoprecipitate with AFAP-110 from chicken embryo fibroblasts. Interactions with the Src SH2 domain binding partner pp130cas were unaffected. Additionally, only chimeras containing the cYes SH2 domain were able to co-immunoprecipitate with an unidentified 87 kDa tyrosine-phosphorylated protein. These results indicate that the SH3 and SH2 domains are capable of directing specificity in substrate binding between Src and Yes, suggesting potential mechanisms for generating specificity in signaling between these two highly related non-receptor tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644991     DOI: 10.1038/sj.onc.1203265

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Role of Src kinases in mobilization of glycosylphosphatidylinositol-anchored decay-accelerating factor by Dr fimbria-positive adhering bacteria.

Authors:  Christophe J Queval; Valérie Nicolas; Isabelle Beau
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Engineered kinase activation reveals unique morphodynamic phenotypes and associated trafficking for Src family isoforms.

Authors:  Pei-Hsuan Chu; Denis Tsygankov; Matthew E Berginski; Onur Dagliyan; Shawn M Gomez; Timothy C Elston; Andrei V Karginov; Klaus M Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-12       Impact factor: 11.205

3.  Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells.

Authors:  Yan-Hua Chen; Qun Lu; Daniel A Goodenough; Beverly Jeansonne
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

4.  Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110.

Authors:  Amanda Gatesman; Valerie G Walker; Joseph M Baisden; Scott A Weed; Daniel C Flynn
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

6.  A dynamic view of domain-motif interactions.

Authors:  Eyal Akiva; Gilgi Friedlander; Zohar Itzhaki; Hanah Margalit
Journal:  PLoS Comput Biol       Date:  2012-01-12       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.